FRED HUTCHINSON CANCER CENTER
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
- Conditions
- First Posted Date
- 2004-04-13
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00014391
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
- First Posted Date
- 2004-04-13
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00010283
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
- Conditions
- First Posted Date
- 2004-04-02
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00005948
- Locations
- 🇺🇸
University of Colorado Cancer Center, Denver, Colorado, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
- Conditions
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Childhood Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesChildhood Renal Cell CarcinomaChronic Phase Chronic Myelogenous LeukemiaClear Cell Renal Cell CarcinomaRecurrent Cutaneous T-cell Non-Hodgkin LymphomaAdult Acute Myeloid Leukemia With Del(5q)
- Interventions
- Drug: fludarabine phosphateRadiation: total-body irradiationProcedure: nonmyeloablative allogeneic hematopoietic stem cell transplantationProcedure: allogeneic bone marrow transplantationProcedure: peripheral blood stem cell transplantationBiological: therapeutic allogeneic lymphocytesDrug: cyclosporineDrug: mycophenolate mofetilOther: pharmacological studyOther: laboratory biomarker analysis
- First Posted Date
- 2004-04-02
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 55
- Registration Number
- NCT00005799
- Locations
- 🇩🇪
Universitaet Leipzig, Leipzig, Germany
🇺🇸City of Hope Medical Center, Duarte, California, United States
🇺🇸Stanford University Hospitals and Clinics, Stanford, California, United States
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
- Conditions
- First Posted Date
- 2004-03-31
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 578
- Registration Number
- NCT00003883
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸University of Washington Medical Center, Seattle, Washington, United States
Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Conditions
- First Posted Date
- 2004-03-25
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00008151
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
- Conditions
- First Posted Date
- 2004-03-19
- Last Posted Date
- 2010-03-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT00002789
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment
- First Posted Date
- 2004-03-10
- Last Posted Date
- 2017-06-20
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 44
- Registration Number
- NCT00079183
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
- Conditions
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Nasal Type Extranodal NK/T-cell LymphomaChildhood Myelodysplastic SyndromesChildhood Nasal Type Extranodal NK/T-cell LymphomaChronic Myelomonocytic LeukemiaAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma
- Interventions
- First Posted Date
- 2004-03-09
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT00078858
- Locations
- 🇺🇸
Stanford University Hospitals and Clinics, Stanford, California, United States
🇺🇸Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States
🇺🇸Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
- Conditions
- First Posted Date
- 2004-02-27
- Last Posted Date
- 2010-06-17
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00024037
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States